I-Linagliptin CAS: 668270-12-0 uMboneleli woMvelisi

I-Linagliptin (amagama orhwebo i-Tradjenta kunye ne-Trajetna) sisithinteli se-dipeptidyl peptidase-4 (DPP-4) eyavunywa yi-US FDA ngoMeyi ka-2011 kunyango lwe-Type 2 yeswekile kunye nokutya kunye nokuzilolonga.I-Linagliptin (BI-1356) ichazwe njengeyona nto inamandla yokukhetha, isantya esicothayo kunye ne-inhibitor esebenza ixesha elide ye-DPP-4.I-Linagliptin ivele kwimizamo yokuphucula i-xanthine-based DPP-4 inhibitors kunye nesikhokelo sokuqala esichongiweyo kwiphulo le-HTS.

Iodolo okanye Cela iQuote

Iinkcukacha zeMveliso

Iithegi zeMveliso

Isicelo kunye nesiphumo

I-Linagliptin (i-TrajentaR, i-Tradjenta TM, i-Trazenta TM, i-Trayenta TM) ngumlomo, i-inhibitor ekhethiweyo kakhulu ye-dipeptidyl peptidase-4 kwaye iyona arhente yokuqala yodidi lwayo oluya kupheliswa ngokugqithiseleyo ngendlela engeyiyo.ILinagliptin isetyenziswa kube kanye yonke imihla kunyango lwabantu abadala abanesifo seswekile esi-2. ILinagliptin yenza umsebenzi wokunciphisa amanqanaba eswekile yegazi ngokuthintela i-enzyme DPP-4, ngaloo ndlela inqanda ukuthotywa kwehomoni ze-incretin (i-glucagon-like peptide-1 [GLP) -1] kunye ne-glucose exhomekeke kwi-insulinotropic peptide) kunye nokunciphisa i-postprandial glucose excursions.

Isampulu yeMveliso

Ukupakishwa kweMveliso:

Iinkcukacha ezongezelelweyo:

Ukuqamba	C25H28N8O2
Isivavanyi	99%
Imbonakalo	Umgubo omhlophe
Inombolo yeCAS.	668270-12-0
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Ugcino	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	ISO.